Figure 1. Case 1, (A) the skin lesions progressed to grade 2 with severe itching. (B) The skin lesions were ameliorated with improved itching after low-dose aspirin was started without dose reduction of erlotinib. Case 2, (C) After 1 week of treatment with erlotinib, a grade 2 skin rash developed with severe itching. (D) The skin lesions were ameliorate with improved itching after low-dose aspirin was started without dose reduction of erlotinib.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.